申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:US05318969A1
公开(公告)日:1994-06-07
A benzopyran compound of the general formula (I) ##STR1## wherein A represents --OR.sup.1 or --NH--COR.sup.2 ; R.sup.3 represents hydrogen, a lower alkyl, a lower alkoxy, amino, a mono- or di-lower alkylamino, an amino-lower alkyl, a hydroxy-lower alkyl, a halo-lower alkyl, a lower alkoxy-lower alkyl, an acyloxy-lower alkyl, a lower alkoxycarbonyl-lower alkyl, an aryl or a heteroaryl, or R.sup.2 and R.sup.3 combinedly together form an alkylene having 1 to 2 carbon atoms; R.sup.4 and R.sup.5 are the same or different, and respectively represent hydrogen or a lower alkyl, or combinedly together form an alkylene having 2 to 5 carbon atoms; R.sup.6 represents hydroxyl group, formyloxy, an alkanoyloxy, a haloalkanoyloxy, a lower alkoxycarbonyloxy, an aroyloxy, a heteroaroyloxy, carbamoyloxy, a mono- or di-lower alkylcarbamoyloxy and R.sup.7 represents hydrogen, or R.sup.6 and R.sup.7 combinedly together form a bond and X and Y are the same or different, and respectively represent hydrogen, halogen, nitro, cyano, a lower alkyl, a lower alkoxy, a halo-lower alkyl, carboxyl, formyl, an alkanoyl, an aroyl, a halo-alkanoyl, carbamoyl, a lower alkylsulfinyl, an arylsulfinyl, a lower alkylsulfonyl, an arylsulfonyl, sulfonamido or a mono- or di-lower alkylsulfonamido, or their pharmaceutically acceptable salts and its pharmaceutical use.
一种苯并吡喃化合物,其通式为(I)##STR1##其中A表示--OR.sup.1或--NH--COR.sup.2; R.sup.3表示氢,低碳基,低烷氧基,氨基,一种单一或双重低烷基氨基,氨基低烷基,羟基低烷基,卤代低烷基,低烷氧基低烷基,酰氧基低烷基,低烷氧羰基低烷基,芳基或杂环芳基,或R.sup.2和R.sup.3结合在一起形成具有1到2个碳原子的烷基; R.sup.4和R.sup.5相同或不同,分别表示氢或低碳基,或结合在一起形成具有2到5个碳原子的烷基; R.sup.6表示羟基,甲酰氧基,烷酰氧基,卤代烷酰氧基,低烷氧羰基氧基,芳酰氧基,杂环芳酰氧基,氨基甲酰氧基,一种单一或双重低烷基氨基甲酰氧基,R.sup.7表示氢,或R.sup.6和R.sup.7结合在一起形成键,X和Y相同或不同,分别表示氢,卤素,硝基,氰基,低碳基,低烷氧基,卤代低烷基,羧基,甲酰基,烷酰基,芳酰基,卤代烷酰基,氨基甲酰基,低烷基磺酰基,芳基磺酰基,低烷基磺酰基,芳基磺酰基,磺酰胺基或一种单一或双重低烷基磺酰胺基,或它们的药学上可接受的盐及其制药用途。